SHR1459

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SHR1459, covering 2021-09-28 to 2023-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy [Phase 2]